SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
New subgroup analysis from Phase III ARASENS trial shows that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel increased overall survival (OS)
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
CHMP recommendation is based on Phase III data, which demonstrated that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel significantly reduced the risk of death by 32.5%
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
Positive opinions based on significant survival benefit
India now has 648 medical colleges in 2022 with a whopping 96% increase in the number of Government Medical Colleges (GMC) alone and a 42% increase in the private sector, since 2014
Subscribe To Our Newsletter & Stay Updated
